News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Independent Study Results Presented At American Society For Dermatologic Surgery Annual Meeting Show That DUSA Pharmaceuticals's (DUSA) Levulan(R) Kerastick(R) Plus Intense Pulsed Light "IPL" Improves Photodamaged Skin More Than IPL Alone



10/19/2005 5:11:45 PM

DUSA Pharmaceuticals, Inc. (NASDAQ:DUSA) is pleased to report that at the annual meeting of the American Society for Dermatologic Surgery in San Diego, held September 30th to October 3rd, 2004, an independent investigator group presented the results of the first prospective, randomized, controlled, split face clinical study using the Levulan(R) (aminolevulinic acid HCl) Kerastick(R) together with intense pulsed light (IPL) for the treatment of photoaging. DUSA provided Levulan and financial support to the investigator group.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES